Arabic Arabic English English French French German German
dark

Artificial intelligence could be new blueprint for precision drug discovery

Writing in the July 12, 2021 online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Webinar to discuss life sciences labelling solutions

Next Post

Thailand sees tougher COVID-19 curbs bite, including Bangkok curfew

Related Posts
Total
0
Share